Table 1.
Demographic, cognitive, and affective measures for pramipexole and placebo groups.
| Measure | Placebo (n = 20; 12 females) | Pramipexole (n = 20; 12 females) | p-value |
|---|---|---|---|
| Age | 20.50 (0.29) | 20.80 (0.21) | 0.405 |
| Education | 15.40 (0.23) | 15.55 (0.20) | 0.628 |
| NART | 118.95 (1.45) | 118.71 (0.99) | 0.892 |
| MOCA | 27.80 (0.34) | 27.80 (0.43) | 1.000 |
| F-words | 14.00 (1.02) | 12.75 (0.83) | 0.347 |
| Clock | 2.95 (0.05) | 2.90 (0.07) | 0.560 |
| Cube | 0.85 (0.08) | 0.90 (0.69) | 0.643 |
| BDI-II | 9.60 (1.61) | 8.05 (1.18) | 0.441 |
| BAI | 8.60 (1.85) | 7.45 (1.38) | 0.622 |
| Apathy | 11.50 (1.07) | 11.20 (0.77) | 0.821 |
Mean values (±SEM) are reported. Education is measured in years. NART, National Adult Reading Test indicates IQ score. The Montreal Cognitive Assessment (MOCA) is scored out of 30, Clock is scored out of 3 and Cube is scored out of 1. BDI-II, Beck Depression Inventory II is scored out of 63; BAI, Beck Anxiety Inventory is scored out of 63. Apathy is scored out of 42.